Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Ockham Research (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Smith & Wesson Has Enough Firepower

% of readers think this story is Fact. Add your two cents.


Smith & Wesson Holding Company (SWHC) has been producing firearms and related produces dating back to 1852.  On Wednesday afternoon the iconic gun maker released earnings totals for fiscal 2010 that exceeded analysts’ expectations on the top-line and many investors have not hesitated to pull the trigger on the small cap stock.  The company reported fourth quarter profit of only $2.7 million or 4 cents per share, which was in line with expectations.  However, revenue of $103.8 million easily topped Wall Street’s view of $98.9 million, and in fact grew 4.3% despite expectations for a slight dip.  For the past fiscal year, SWHC has earned 32 cents per share on revenue of $404 million.  The stock traded nearly 7% higher on Thursday as a result of the earnings and guidance announcement.

For the year, Smith & Wesson saw sales leap nearly 21% over fiscal 2009, and perhaps more impressively, they reported their backlog of orders had grown 23% to $143.1 million over the total backlog just a quarter ago.  Strong demand for their products also allowed management to guide for fiscal 2011 sales of $430 million to $445 million.  Clearly, the company was pleased to see the US Supreme Court’s decision that the Chicago-area ban on handguns as unconstitutional, which can only be considered a positive for the industry and SWHC’s prospects going forward.

Not surprisingly, two notable Wall Street analysts are looking more favorably on the company as sales trends look to continue recent strong momentum.  As Merriman Curhan Ford analyst Eric Wold said in his not upgrading SWHC from neutral to buy this morning, “With the improved backlog outlook and visibility it brings, we are now comfortable once again moving off the sidelines and recommending purchase of the shares at current levels.”  We tend to agree with Wold, but we are content to leave our rating unchanged at Undervalued.  The stock trades near the low end of both its historical price-to-cash earnings and price-to-sales ranges.  But even more impressive to us is the revenue growth that SWHC has produced in the last few years.  On average for the last four years, they have seen sales grow at an annual rate of 26% and such strong growth is always looked upon favorably in our analysis.

Management is doing a good job of driving growth forward with new guns consumers are eager to buy, and they are looking to grow their defense contracting business.  At the current price level, we believe the potential reward outweighs the risks over the long term, and value investors should keep an eye on SWHC.  We would not consider the 2007 highs of $20-plus per share to be a realistic target, but we do think that this stock could trade in the high single digits as it continues to grow sales and earnings.

Read the original story at Ockham Research



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login